Silver Book Fact

Parkinson’s disease is the 2nd-most common neurodegenerative disease in the U.S., second only to Alzheimer’s disease.

Nussbaum R, Ellis C. Genomic Medicine: Alzheimer’s Disease and Parkinson’s Disease. N Engl J Med. 2003; 348(14): 1356-64. http://www.nejm.org/doi/full/10.1056/NEJM2003ra020003

Reference

Title
Genomic Medicine: Alzheimer’s Disease and Parkinson’s Disease
Publication
N Engl J Med
Publication Date
2003
Authors
Nussbaum R, Ellis C
Volume & Issue
Volume 348, Issue 14
Pages
1356-64
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • In addition to the estimated $14.4 billion a year in costs for Parkinson’s disease to the nation, an additional $6.3 billion in indirect costs (missed work or loss of job…  
  • The costs to other payers (beyond Medicare, Medicaid, and out-of-pocket) will increase more than 400% between 2010 and 2050–from $22 billion to $117 billion.  
  • For people with Alzheimer’s disease, aggregate payments for health care, long-term care, and hospice are projected to increase from $200 billion in 2012 to $1.1 trillion in 2050.  
  • Dementia prevalence was found to increase with age, from 5% of those Americans aged 71-79 years to 37.4% of those aged 90 and older.  
  • In 2005, the average length of hospice stays for Medicare beneficiaries with Alzheimer’s disease was 99 days.